Jill Bargonetti

Research Focus: Signal Transduction|Cancer/Cell Division and Death|Gene Expression/Regulation

Jill Bargonetti, a renowned cancer researcher, earned her B.A. at SUNY College at Purchase and her Ph.D. at New York University and did postdoctoral work at Columbia University. She serves as chair of the Molecular, Cellular, and Developmental Biology subprogram of the Ph.D. Program in Biology at The Graduate Center and as professor of biological sciences at The Graduate Center and Hunter College. Since 1994, she has been running the Bargonetti Lab at Hunter College, where her team is using genetically engineered tools to research breast cancer.
 
Bargonetti has published her research in prestigious scientific journals including Cell, Nature, Genes and Development, Proceedings of the National Academy of Sciences, and Cancer Research. She served as a standing member of the Tumor Cell Biology study section grant review panel for the National Institutes of Health (NIH) from 2012 to 2018. She has received research grants from the National Institutes of Health, the National Science Foundation, the Breast Cancer Research Foundation, the American Cancer Society, and the Department of Defense. She has been honored by the U.S. government as an innovator in the education of minorities in science. Her awards include the Presidential Early Career Award for Scientists and Engineers, from President Bill Clinton; the New York City Mayor’s Award for Excellence in Science and Technology; the New York Voice Award (given to those who have made a significant improvement to the quality of life in New York City); the Kathy Keeton Mountain Top Award from the New York branch of the NAACP; the Outstanding Woman Scientist Award from the Association for Women in Science; the NYU Graduate School of Arts and Science and SUNY Purchase Outstanding Alumnae Achievement Awards and has been named to the Bronx High School of Science Hall of Fame. Bargonetti was profiled by Working Mother magazine as one of the nation’s “Stellar Moms.” Her work is currently funded by the Breast Cancer Research Foundation and the National Institutes of Health.